Payton Nyquvest

Payton is the Co-founder, Chair & Chief Executive Officer of Numinus, a company that empowers people to heal and be well through the development and delivery of innovative mental health care and access to safe, evidence-based psychedelic-assisted therapies. He has a deep understanding of the psychedelic industry from its infancy, driven by life-saving personal experiences with multiple therapy modalities. Suffering from severe chronic pain and auto-immune issues from birth, along with PTSD, compelled Payton to seek out psychedelics, which he attributes to saving his life. A recognized innovator and visionary in mental health care, Payton guides teams at Numinus through strategy, innovation, research and clinic network expansion, and supports the marketing and capital markets functions.